Objectives. To examine the descriptive epidemiology of the patient population referred to paediatric rheumatology centres (PRCs) in Southeast Asia (SEA) and to compare the frequency of conditions encountered with other PRC populations.
Introduction
Five decades ago, paediatric rheumatology was first established as a new discipline in paediatrics. Since then, the territory of this subspecialty has expanded, not only with the discovery of novel autoimmune/inflammatory diseases, but also with raised awareness of existing diseases [1] . Determining the paediatric rheumatology patient population and referral pattern is crucial for local paediatricians and rheumatologists to know local rheumatic disease (RD) epidemiology and to raise awareness leading to early detection; for diagnosis and management; for local health authorities to prioritize healthcare delivery; and for researchers to study the role of genetic diversity and environment in the immunopathogenesis of RDs. Since the 1990s, a few articles have described the patient population in the West (USA, UK and Canada), but there has been only one recent report from Asia (Israel) [16] . No data are available for Southeast Asia (SEA), where the shortage of paediatric rheumatologists is severe and certain life-threatening RDs may be more prevalent, such as SLE and systemic vasculitides [79] .
There are nine developing and two developed (Singapore and Brunei) countries in SEA, with a population of over 618 million (14% of the Asian or 8% of the world population) (Fig. 1) [10, 11] . However, in only four countries (Malaysia, the Philippines, Singapore and Thailand) are there dedicated paediatric rheumatology academic programmes with trained paediatric rheumatologists. The Asia-Pacific Paediatric Rheumatology Education and Research Network (AsPREN) was formed in 2011 with main aims to facilitate research collaboration and to establish dedicated paediatric rheumatology fellowship training programmes for the region [8] . A web-based Registry for Childhood Onset RDs was developed in Singapore in January 2009 serving as a platform for data collection. The purpose of this registry was to collect epidemiological and outcome data to facilitate local and regional research in the field. We report for the first time the paediatric rheumatology clinic/referral populations in the above four SEA countries with comparisons with those reported elsewhere.
Methods

Patient registration
All patients evaluated in the participating centres from 1 January 2011 to 31 December 2012 were recruited, except for those in Singapore, which included patients seen since the academic programme inception, from 1 January 2009 to 31 January 2014. Demographic data including gender, race, date of birth, address, diagnosis and date of onset and diagnosis were collected anonymously with an automatic patient code assignment through our web-based registry [12] . Participating centres include only those with academic paediatric rheumatologists-Malaysia (S.P.T., Selayang Hospital, Kuala Lumpur), the Philippines (C.B.B., University of Santo Tomas Hospital, Manila), Singapore (T.A., KK Women's and Children's Hospital and E.A., National University of Singapore Hospital), and Thailand (T.D. and G.P., Queen Sirikit's National Institute of Child Health; S.V., Ramathibodi Hospital; S.C., Siriraj Hospital, Mahidol University, Bangkok)-with a median experience in paediatric rheumatology practice of 5.14 years (interquartile range: 1.09.0). An assigned password was used to access the registry and only investigators at the same centres could access their patients' confidential data. Duplicate entries were detected by identical birth date and initials. KK Women's and Children's Hospital in Singapore served as the coordinating centre. SingHealth Centralized Institutional Review Board and respective Institutional Review Boards of each participating centre approved the study. This study was given the waiver of informed consent, and therefore patients were not required to sign a consent form.
Disease definitions
Generally accepted diagnostic and classification criteria were applied to categorize patients [1316] . Criteria proposed by Rosenberg were adopted for less common conditions [6] . Changes in diagnoses were allowed and final diagnoses were used for analysis. RDs were defined as conditions for which paediatric rheumatologists were the primary decision maker on the diagnosis and treatment. Non-RDs (non-RD) were orthopaedic conditions, conditions where paediatric rheumatologists assisted in management only, or non-systemic or single organ-specific autoimmune diseases, or abnormal immunological tests without specific RDs.
Statistical analysis
All analyses were performed using SPSS, version 23.0 (IBM Corp., Armonk, NY, USA) with statistical significance set at P < 0.05. The differences across the countries on the various disease prevalences were compared using the chi-square test or Fisher's exact test where appropriate.
Results
Characteristics of the patient population
A total of 4038 patients were registered from the four SEA countries. The data collection period and numbers of patients registered from each country are shown in Table 1 . Ethnicity distributions generally represented those of each country. More females were encountered than males in Malaysia (2:1) and Thailand (1.5:1), but an equal gender distribution was observed in the Philippines and Singapore. Average age at diagnosis was around 89 years across all countries. Except for those from Singapore, patients referred to paediatric rheumatologists in the three remaining countries had RDs in >70% of cases, compared with almost one-half with nonrheumatological conditions in Singapore.
Disease distributions
RD distributions
The frequencies and proportions of RDs from each participating country are illustrated in Table 2 and Fig. 2 , which demonstrated certain discrepancies in disease distribution. JIA was the most common RD encountered in Malaysia and Thailand while it was systemic vasculitides in the Philippines and Singapore (P < 0.001). The proportions of SLE in the developing countries (16.023.5%) were at least double that in the developed country (Singapore, 7.1%, P < 0.001). Furthermore, SLE was the overall most common CTD (51.183.3%), followed by JDM (5.920.2%), and Malaysia had the highest proportion of the latter (6.9%, P < 0.001). APS was very rare (00.4% of all RD). Among vasculitides, HenochSchö nlein purpura (HSP) was the most prevalent condition (32.655.5%), evaluated regionally. The Philippines and Singapore seemed to see a higher number of HSP patients, accounting for one-fifth of total RDs encountered (P < 0.001), or 40.8% and 55.5% of all systemic vasculitides evaluated, respectively. Kawasaki disease was also much more common in the clinics of the above two countries, although it was rarely seen in paediatric rheumatology centres (PRCs) in Malaysia and Thailand (36.5, 33.4, 9.2 and 0% of all vasculitides, respectively) during the study period. There was not a single case of PAN in the Singaporean clinic population. Only one case each of granulomatosis with polyangiitis and microscopic polyangiitis was encountered in Thailand and the Philippines, respectively. Scleroderma of both systemic (01.4%) and localized (00.9%) forms, and amplified pain syndrome (0.23.3%) were uncommon. Primary CNS vasculitis was diagnosed more often in Singapore (1.0%). Post-infectious or reactive inflammatory conditions including transient synovitis, reactive arthritis and myositis were encountered commonly in the   FIG. 1 Gross domestic product and healthcare workforce density for each Southeast Asian country Data taken from [10, 11] . GDP: gross domestic product. Philippines (17.0%) and Singapore (19.5%) as compared with the other two neighbouring countries. Acute rheumatic fever seemed to be rare in Malaysia (n = 0) and Singapore (n = 1), while it was encountered in the Philippines (n = 11, 2.1% of RD) and Thailand (n = 6, 1.2% of RD). IBD-associated arthritis was not uncommonly referred to paediatric rheumatologists for comanagement [Malaysia (n = 4, 0.7%), the Philippines (n = 5, 1.0%), Singapore (n = 12, 1.2%), Thailand (n = 8, 1.5%)]. Only one case each of sarcoidosis and relapsing polychondritis from Malaysia and one case of the latter from Thailand was reported. Autoinflammatory diseases were rare, among which two chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome, one FMF and two SAPHO from Singapore, three chronic infantile neurological cutaneous and articular (CINCA) syndrome and one chronic recurrent multifocal osteomyelitis (CRMO) from Malaysia, and one CINCA syndrome and one CRMO from Thailand were registered. No Lyme disease was observed in the region. The distributions of JIA subtypes were different (Table 3) . Systemic onset JIA (SoJIA) was the most common JIA subtype in Malaysia (35.3%) and Thailand (33.4%), while polyarticular, RF negative was the most common JIA subtype in the Philippines (46.7%), and enthesitis-related JIA in Singapore (32.9%). As for SoJIA, the clinical presentations were not significantly different among the countries in the region. Moreover, the clinical manifestations at presentation were not significantly different from those reported in the West. All patients with SoJIA during the study period had fever and arthritis and about three-quarters of cases had a typical salmon-pink rash at presentation. Hepatosplenomegaly and lymphadenopathy were presented in 70% of cases. Macrophage activation syndrome complicated SoJIA was rarer. Only 2 out of 107 (1.9%) and 1 out of 83 (1.2%) cases were reported from Thailand and Malaysia, respectively. There was no mortality of SoJIA associated macrophage activation syndrome during the study period (SPT, unpublished data). Persistent oligoarticular JIA was found in a higher proportion of cases in Singapore (29.2%) as compared with neighbouring countries. PsA was uncommon regionally (0.42.4%).
Non-RD distributions
Among non-RDs, orthopaedic conditions were the most prevalent, including 48 cases (21.7%) from Malaysia, 114 cases (59.4%) from the Philippines, 493 cases (52.0%) from Singapore and 20 cases (26.7%) from Thailand. As shown in Table 4 , mechanical joint pain including overuse, mild localized hypermobile joints, strain and sprain contributed one-third of non-RDs encountered in Singapore. Growing pain was identified the most in the PRC in the Philippines (35.9%, P < 0.001). The number of cases diagnosed with benign hypermobility syndrome in Singapore and the Philippines was double that in the other two countries (P = 0.008). Conditions including Kikuchi disease (n = 18), recurrent aphthous stomatitis (n = 28) and recurrent parotitis (n = 13) were encountered commonly in Singapore compared with other PRCs. Isolated idiopathic uveitis, autoimmune eye diseases and immune-mediated CNS conditions among other immune-mediated organspecific diseases were not uncommonly referred to PRCs in Singapore. Higher proportions of malignancyassociated arthritis were referred to PRCs in Malaysia and Thailand (P < 0.001). The PRCs in the Philippines and Singapore encountered more referrals for fever of unknown origin (FUO) than those in the other two countries (6.97.3% vs 02.3%, P = 0.002). Referrals for an abnormal laboratory test including ANA positivity were uncommon in this region (07.9%). A wide variety of other non-RDs were also referred to SEA PRCs despite their low numbers (Supplementary Table S1 , available at Rheumatology Online).
Discussion
Paediatric rheumatology is known as the discipline in paediatrics that evaluates and manages multi-systemic inflammatory conditions and triages and/or manages musculoskeletal pain complaints in children [17] . The field has expanded as new diseases have been identified and certain organ-specific autoimmune or inflammatory diseases require paediatric rheumatologist expertise in co-managing immunosuppressive and/or biological therapies, as demonstrated in our report. We describe for the first time the paediatric rheumatology clinic populations in SEA for which data were collected prospectively for at least 24 months by trained and experienced paediatric rheumatologists. Many unique observations were made and will be discussed below.
First, the proportions of RD and non-RD were different among the participating countries. Almost three-quarters of clinic populations from Malaysia, the Philippines and Thailand were RD, compared with only one-half of cases reported from Singapore. The lower proportion of RD observed from Singapore was similar to those reported by Bowyer et al. from the USA (40.5%), Rosenberg from Canada (50.9%) and Hashkes from Israel (51%) [1, 3, 6] . Disease awareness, socioeconomic status, healthcare accessibility and, most importantly, availability of paediatric rheumatologists may be the main reasons for the above similarity. Singapore is the only high-income economy or developed country where healthcare is largely subsidized and well accessible as the country is an island city-state and relatively small compared with the other three neighbouring countries, where it is more expensive and limited [10, 18, 19] . Furthermore, there are currently four full-time clinical paediatric rheumatologists in Singapore serving a population of 5.8 million, which is adequate for the country. This subspecialist-population ratio is, however, 3 to 30 million in Malaysia, 10 to 102 million in the Philippines and 4 to 65 million in Thailand, severely lower compared with Singapore and many countries of the West [8, 20] . Moreover, the awareness of RDs of both local physicians and the general public is expected to be low due to lack of paediatric musculoskeletal and autoimmune/inflammatory disorder education in medical schools. In addition, playing a significant role in determining the disease profile encountered in a clinic population, the healthcare-seeking behaviour is heavily shaped by cultures and beliefs [21] . SEA is rich and varied in its cultures, with diverse religions and beliefs, even within the same ethnic groups [10] . Despite this, SEA's people still believe in balance and harmony and that illnesses largely result from imbalance [22] . Correcting such imbalance through traditional or alternative/complementary medicines remains a common practice regionally. Pain is the main complaint in the majority of patients referred to rheumatologists. Pain perception and pain behaviour may influence caregiver illness perception and healthcare-seeking decisions. They have been shown to be different across ethnicities and cultures [21, 23, 24] . People in the East tend to have higher pain tolerance than those in the West [21] . Stoicism could occasionally be seen in certain ethnic groups in our region [25, 26] . In Singapore, related to the higher economic status of the country, the average level of education is higher as compared with the neighbouring countries [18] . This may shape caregivers' illness perception and healthcare-seeking behaviours in addition to other above-mentioned factors, thus explaining this RD and non-RD proportion discrepancy.
Second, JIA was the most common RD encountered in the West, accounting for 48.6% in the USA and 66.5% in a Canadian RD population [1, 6] . This was also observed in Malaysia (41.9%) and Thailand (61.4%), but not in the Philippines (24.3%) or Singapore (27.5%). Systemic vasculitides, surprisingly, were the most common RDs encountered in the latter two countries, contributing to 37.0 and 35.5% of the RD cases, respectively. Only <10% of US and Canadian RD were vasculitides [1, 6] . As expected, HSP was the most common systemic vasculitis seen around the world. Interestingly, Kawasaki disease was rarely if ever seen by Thai and Malaysian paediatric rheumatologists, suggesting that the majority of their Kawasaki disease cases were exclusively taken care of by paediatricians and/or paediatric cardiologists. Furthermore, there was no PAN reported from Singapore, for which the reason remains unknown.
Third, the subtypes of JIA distributions were unique among AsPREN member countries. As compared with the West, where persistent oligoarticular type JIA was the most prevalent, SoJIA was the most common JIA encountered in Malaysia (35.3%) and Thailand (33.4%), followed by RF-negative polyarticular (32.3%) and persistent oligoarticular JIA (11.5%) in Malaysia and enthesitisrelated arthritis (20.4%) and RF-negative polyarticular JIA (19.4%) in Thailand. Almost one-half of Filipino JIA was of the RF-negative polyarticular type (46.7%) followed by SoJIA (26.2%) and enthesitis-related arthritis (13.5%), while one-third of Singaporean JIA was the enthesitis-related subtype (32.9%) followed by persistent oligoarticular (29.2%) and RF-negative polyarticular (13.9%) JIA. Genetic diversity may be the main reason for the discrepancies in the profile of JIA subtypes in the region.
Fourth, SLE was undoubtedly more common in our region (7. 123.5% of all RD) as compared with the West (4.4% of US RD and 3.2% of Canadian RD) [1, 6] . Surprisingly, it was 23 times less frequent in Singapore compared with her neighbours. Referral bias cannot be totally discredited as the severe morbidity caused by the disease tends to urge caregivers to seek medical attention earlier.
Fifth, among CTDs, JDM was not uncommon and Malaysia had the most (6.9% of all RD), and the Philippines had the least (1.2%). SSc was rare and the frequency was comparable to those reported from the West [1, 6] . However, Singapore did not report a single case during the study period. Localized scleroderma was likely to be managed by local dermatologists as it was less frequently encountered in our rheumatology clinics (00.9%) as compared with those reported from the USA (1.5% of RD) and Canada (1.74% of RD) [1, 6] . This may also be true for discoid lupus cases as no report was from the Philippines or Thailand.
Sixth, idiopathic or amplified pain syndrome was uncommonly seen in our region (0.23.3% of RD) compared with those reported from the USA (13.8% of RD) and Canada (4.6% of RD) and much lower than Israel (24.9% of RD) [1, 3, 6] . This can be partially explained by the differences in pain perception and healthcareseeking behaviour.
Seventh, autoinflammatory disorders were rare and comparable among AsPREN PRCs (P = 0.101). The frequencies were much less than that reported from the Middle East and Israel (18.8% of RD) [3] . Reactive or post-infectious arthritis or myositis was not uncommon, accounting for almost one-fifth of RD cases in the Philippines and Singapore, compared with 11.5% in the US PRCs and one-third in Israel [1, 3] . While the incidence of ARF has been declining in many parts of the world in the past two decades, data on its epidemiology in SEA are lacking [2731] . Interestingly, paediatric rheumatologists from Singapore and Malaysia rarely encounter this condition (only one case from Singapore and none from Malaysia). This could mean that either the true incidence of ARF was low, or cases of ARF were not referred or managed primarily by rheumatologists in both countries since up to one-third of patients had no arthritis and even so, arthritis in ARF responded well to aspirin or NSAIDs, if it was not self-limiting without therapy [29] .
Eighth, among non-RD, orthopaedic conditions comprised the largest referrals in our region, in accordance with those reported elsewhere [1, 6] . Mechanical or noninflammatory joint pain and growing pain accounted for the majority in Singapore and the Philippines, respectively. Cases of FUO were diagnosed by paediatric rheumatologists in these two countries, despite being <10% of total non-RD, compared with the other two neighbouring countries (41%). While infection remains the major cause for FUO, RDs especially CTDs are the second most common cause of FUO in children [32] . Our data suggested that despite paediatric rheumatology evaluation, <10% of FUO causes remained unknown or had no final diagnosis in our region, which was less than that reported elsewhere [32] .
Certain limitations in our study warrant discussion. The population incidence and prevalence could not be calculated and we believe that it is impossible as long as the shortage of paediatric rheumatologist remains severe and the distribution of PRCs remains in the urban area of each country in SEA. This issue may be less only in Singapore due to its small size and being an island state, and the collection of epidemiological data has been on-going. Although certain childhood-onset RD diagnostic criteria have been developed, many are still lacking. In our study, the diagnosis was made in each participant centre by one or two paediatric rheumatologists who were fully trained in the area for at least 23 years if not more (from USA, Canada or UK), with experience of up to 10 years at the time of the study. These physicians have the credentials to accurately diagnose and manage RDs in children. The well-accepted diagnostic criteria and definitions of conditions were used as mentioned above. We believe that our data truly reflect the true frequencies of the paediatric rheumatology referral populations in our region. In addition, missing data are inevitable for such a large dataset. However, there was no missing diagnosis in our study, and the most incomplete were the date of birth and/or date of diagnosis (10.03% of the total cohort), which should not affect the calculation of condition frequencies. The strength of our study includes the use of web-based data collection in which each multi-site physician could enter data and modify data once the final diagnosis was reached. The records were linked so that duplication of subjects could be avoided. Explicit diagnostic criteria defining the cases were determined at the time of patient evaluation by a paediatric rheumatologist rather than a review of medical records.
In summary, we have shown that ethnic differences may affect the frequencies of RDs in children, even in the same region of the world. Systemic vasculitis and SLE and related diseases are more prevalent in our region. Different subtype prevalence of JIA was evident according to geographic and racial differences. Our data will guide healthcare delivery priority, paediatric rheumatology fellowship training curricula and research development in our region. 
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